MapLight Therapeutics is a clinical stage biotech company dedicated to drug discovery for central nervous system disorders. Utilizing advanced technologies such as optogenetics, in vivo physiology, and spatial transcriptomics, the company aims to identify novel drug targets and develop effective therapies to address psychiatric symptoms. With a focus on innovation and collaboration, MapLight Therapeutics is committed to improving the lives of individuals affected by these challenging conditions.